Navigation Links
Campbell Alliance Adds Doug Linton, Former Cardinal Health Executive, to Executive Advisory Group
Date:4/28/2008

RALEIGH, N.C., April 28 /PRNewswire/ -- Campbell Alliance, the leading management consulting firm specializing in the pharmaceutical and biotech industry, today announced that Doug Linton has joined its Executive Advisory Group. The group is made up of industry professionals brought together by Campbell Alliance CEO John Campbell to bring special expertise to highly complex engagements. Mr. Linton will focus on distribution-related issues, working closely with Campbell Alliance's Trade and Distribution Practice.

Mr. Linton started with Cardinal Health, a global manufacturer and distributor of medical and surgical supplies and technologies, in 1981, and he has worked in the pharmaceutical distribution field for more than 20 years. At Cardinal, he played a key role developing the sophisticated investment buying program and central purchasing system that powered the firm's consolidation strategy, which transformed it from a small regional player in the early 1980s to a highly profitable national drug wholesaler by the mid- 1990s. Mr. Linton also developed and was president of several very profitable new business units for Cardinal, including National PharmPak Services, a re- packaging company, and National Specialty Services, which focused on distribution of plasma and oncology products. Mr. Linton reported to the founder and CEO of Cardinal Health during a majority of his tenure and was a member of senior management.

After leaving Cardinal in 1995, Mr. Linton worked as a senior executive with two regional drug wholesalers to develop purchasing capabilities similar to those he established at Cardinal. He then returned to Cardinal as a consultant to develop an analytical fee-for-service program for smaller manufacturers, and he directed its implementation with more than 60 manufacturers in less than twelve months. Today that program is used with close to 200 manufacturers.

After leaving Cardinal two years ago, Mr. Linton consulted to over 20
'/>"/>

SOURCE Campbell Alliance
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Campbell Alliance to Moderate Senior-Level Panel Discussion at Windhover Pharmaceutical Strategic Alliances Conference
2. Campbell Alliance Managed Markets Practice to Take Leadership Role at CBIs Formulary and Reimbursement Conference
3. Campbell Alliance Named Best Place to Work by Triangle Business Journal
4. Campbell Alliance Business Development Practice to Moderate Two Workshops at LES Annual Meeting in Vancouver
5. Campbell Alliance Launches New Practice Area Focused on Trade and Distribution
6. Campbell Alliance Trade and Distribution Practice to Chair CBI 3rd Annual Fee for Service and EDI Data Management Conference
7. Campbell Alliance Brand Management Practice to Discuss Managing Launch Logistics at the EyeForPharma Oncology Summit
8. Campbell Alliance Brand Management and Managed Markets Practices to Speak at CBIs Early Commercialization Conference
9. Campbell Alliance Sales Practice to Conduct Workshop at EyeForPharma SFE Europe Conference
10. Campbell Alliance Managed Markets Practice to Take a Leadership Role at the CBI Forum on Effective Product Pricing and Modeling Strategies
11. Heritage and Ipca Enter Into Strategic Alliance for Generic Pharmaceutical Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... Dallas, Texas (PRWEB) December 23, 2014 ... on methyl mercaptan such as its definition, ... also presents product specification, manufacturing process, and ... regions, technology and applications. The analysis also ... survey, marketing channels, industry development trend and ...
(Date:12/24/2014)... 24, 2014 The report expects global ... by 2019. It also provides a carefully analyzed data ... challenges for the market. , Full Copy of Report ... the global market for cell expansion will keep witnessing ... expects this growth to be driven by rapid technological ...
(Date:12/24/2014)... 2014 China Biologic Products, Inc. (NASDAQ: ... fully integrated plasma-based biopharmaceutical company in ... subsidiary, Shandong Taibang Biological Products Co. Ltd., has ... China Food and Drug Administration (the "CFDA") for ... disclosed in the Company,s public filings, the CFDA ...
(Date:12/24/2014)... LONDON , December 23, 2014 ... Review Algeria , out today and available for free ... the actors driving change and growth in the sector today. ... has scored notable successes has been in developing a homegrown ... 70 percent local production still remains some way off. A ...
Breaking Biology Technology:Worldwide Methyl Mercaptan Market 2015-2020 Forecasts on Development & Trends Now Available at ReportsnReports.com 2The Cell Expansion Market is Expected to Reach $14.8 billion by 2019 - New Research Report by MarketsandMarkets 2The Cell Expansion Market is Expected to Reach $14.8 billion by 2019 - New Research Report by MarketsandMarkets 3China Biologic Receives GMP Certification for New Coagulation Factor Facility 2China Biologic Receives GMP Certification for New Coagulation Factor Facility 3PharmaBoardroom Releases New Algeria Pharmaceuticals Report 2PharmaBoardroom Releases New Algeria Pharmaceuticals Report 3
... , , SEATTLE and ATLANTA, ... it has signed a lease agreement with Majestic Realty Co. to build ... to manufacture PROVENGE(R) (sipuleucel-T) for patients with advanced prostate cancer. The ... , , If approved by the U.S. Food and ...
... , , , , ... results for its first fiscal quarter ended June 30, 2009. Net sales increased 22% ... year. , , Net loss for the quarter was ... of the prior fiscal year of $587,000 or $0.05 per share. The prior ...
... BOZEN, Italy, August 10 , ... Robotics , Health Robotics today announced ... for Health Robotics, CytoCare Robot. The,agreement enables McKesson to achieve ... Oncology I.V. admixtures. , "We are ...
Cached Biology Technology:Dendreon Signs Lease for New Manufacturing Facility in Atlanta 2Dendreon Signs Lease for New Manufacturing Facility in Atlanta 3Imagenetix, Inc. Reports First Quarter 2010 Results 2Imagenetix, Inc. Reports First Quarter 2010 Results 3Imagenetix, Inc. Reports First Quarter 2010 Results 4Imagenetix, Inc. Reports First Quarter 2010 Results 5McKesson Expands Pharmacy Automation Product Portfolio to Include I.V. Therapy 2McKesson Expands Pharmacy Automation Product Portfolio to Include I.V. Therapy 3
(Date:12/11/2014)... Dec. 09, 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/9ql3kr/biometrics_market ) has announced the ... 2015-2019" report to their offering. ... is the adoption of multimodal biometric systems. Multimodal ... an individual for verification and identification purposes. This ...
(Date:12/11/2014)... ST. PAUL, Minn. , Dec. 10, 2014 ... in wireless physiologic monitoring, has released a new ... changing needs of preclinical toxicology researchers. M series, ... to help toxicologists collect the best possible physiologic ... studies. Adding functional endpoints to toxicology ...
(Date:12/10/2014)... 2014  Valencell, a leader in performance biometric data ... demand from its licensees for highly accurate, clinically validated ... solely coming from fitness and health sectors, but first ... wearable is only as useful as the biometric data ... driver in long-term mass consumer adoption of wearable products," ...
Breaking Biology News(10 mins):Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2New telemetry implants expected to change how large animal toxicology studies are conducted 2Wearable Technology Products Demand Highly Accurate Biometric Technology 2
... Researchers with the UC Davis MIND Institute and Agilent ... disorder best known for causing an insatiable appetite that ... the loss of non-coding RNAs, resulting in the dysregulation ... metabolic differences during sleep. The research was led ...
... YORK, NY (June 25, 2013) Researchers at Columbia ... called caspase-2 is a key regulator of a signaling ... The findings, made in a mouse model of Alzheimer,s, ... damage and subsequent cognitive decline associated with the disease. ...
... added another piece to the evolutionary puzzle to explain why ... remained tiny. In research published in Proceedings of ... including Monash University,s Dr Alistair Evans proposed a new theory ... shrew which weighs around two grams, to the blue whale ...
Cached Biology News:Symptoms of Prader-Willi syndrome associated with interference in circadian, metabolic genes 2Study identifies protein that contributes to cognitive decline in Alzheimer's 2From minute to massive -- mammal size evolution explained 2
Collected from sexually mature, mixed sex, mixed breed guinea pigs. Pricing: $120/unit for 1 - 10 units...
SEQUENASE PCR PRODUCT PRE-SEQU, 1 EA. Category: SEQUENASE....
Mouse monoclonal [IFR0104] to Salmonella enteriditis ( Abpromise for all tested applications)....
All serum is collected from adult animals aged 6 months or older. Certified U.S. orgin. Pricing: $35/unit for 1 - 10 units...
Biology Products: